Regencell Bioscience Holdings (Regencell Bioscience Holdings) Total Debt per Share

: $0.04 (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

$0.04 (As of Jun. 2023)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Regencell Bioscience Holdings's Total Debt Per Share for the quarter that ended in Jun. 2023 was $0.04.

Regencell Bioscience Holdings Total Debt per Share Historical Data

The historical data trend for Regencell Bioscience Holdings's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Total Debt per Share

0.17

0.24

0.29

0.06

0.04

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Debt per Share	Get a 7-Day Free Trial				0.29	-	0.06	-	0.04

Regencell Bioscience Holdings Total Debt per Share Calculation

Regencell Bioscience Holdings's Total Debt Per Share for the fiscal year that ended in Jun. 2023 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(0.03	+	0.44)	/	13.01
	=	0.04

Regencell Bioscience Holdings's Total Debt Per Share for the quarter that ended in Jun. 2023 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(0.03	+	0.44)	/	13.01
	=	0.04

Regencell Bioscience Holdings Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Total Debt per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.